Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
---|
10/27/1994 | DE4313118A1 Use of 1,2,3,4-tetrahydroisoquinoline derivatives as antimycotics |
10/27/1994 | CA2161122A1 Biocompatible implant for expression and secretion of a therapeutic compound in vivo |
10/27/1994 | CA2161097A1 Neural thread protein gene expression and detection of alzheimer's disease |
10/27/1994 | CA2160878A1 Encapsulation of nucleic acids with conjugates that facilitate and target cellular uptake and gene expression |
10/27/1994 | CA2160869A1 Michellamines useful as antiviral agents |
10/27/1994 | CA2160481A1 Tetrahydro-beta-carbolines |
10/27/1994 | CA2160480A1 Tetrahydro-pyrido-indole |
10/27/1994 | CA2160371A1 Method for treatment of menopausal and premenstrual symptoms |
10/27/1994 | CA2160370A1 Derivatives of triterpenoid acids and uses thereof |
10/27/1994 | CA2160224A1 Bispecific antigen-binding molecules |
10/27/1994 | CA2160113A1 Heterocyclic derivatives in the treatment of ischaemia and related diseases |
10/27/1994 | CA2160112A1 Novel polycyclic systems, and derivatives thereof, as neurotransmitter release enhancers useful in the treatment of cognitive disorders |
10/27/1994 | CA2160020A1 Indole derivatives as 5-ht1a and/or 5-ht2 ligands |
10/27/1994 | CA2159738A1 Use of neuro-derived fetal cell lines for transplantation therapy |
10/27/1994 | CA2138297A1 Novel pharmaceutical use of dihydropyridine derivative |
10/27/1994 | CA2137148A1 Biologically active ureido derivatives useful in the treatment of lentivirus-induced disease |
10/27/1994 | CA2135782A1 Ornithine decarboxylase inhibiting cyclic aminooxy compounds |
10/27/1994 | CA2135781A1 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
10/27/1994 | CA2094843A1 Use of disulfiram to prevent neurologic and cardiovascular damage |
10/26/1994 | EP0621282A1 3-Deoxyoligosaccharides, process for their preparation and pharmaceutical compositions containing them |
10/26/1994 | EP0621276A1 Angiotensin II receptor blocking 2,3,6-substituted quinazolinones |
10/26/1994 | EP0621271A1 Benzoxazole derivatives and their use as serotonin 5-HT3 receptor antagonists |
10/26/1994 | EP0621270A1 Collagenase inhibitor |
10/26/1994 | EP0621269A1 Alkyl substituted nitroimidazole acetic acids |
10/26/1994 | EP0621263A2 External anti-inflammatory and analgesic plaster preparation |
10/26/1994 | EP0621255A1 Substituted phenoxy-isobutyric acids and esters |
10/26/1994 | EP0621038A1 Pharmaceutical compositions containing silicate polymers |
10/26/1994 | EP0621037A1 Pyrido-pyrimidinediones, process for their preparation and their use as pharmaceuticals |
10/26/1994 | EP0621036A1 Aqueous compositions comprising argatroban and cyclodextrin or caffeine |
10/26/1994 | EP0621035A1 2[[2-(N-isobutyl-N-methyl)amino]-benzylsulfinyl]benzimidazole as antimicrobial agent against Helicobacter pylori |
10/26/1994 | EP0621034A1 Composition containing aluminium complexes for the treatment of chemical or heat burns |
10/26/1994 | EP0621033A1 Antibiotic composition containing oxytetracycline and glycofurol |
10/26/1994 | EP0621031A2 Ointment for wound treatment |
10/26/1994 | EP0621030A1 Use of benzomorpholine derivatives in skin whitening cosmetic or dermopharmaceutical compositions |
10/26/1994 | EP0620833A1 Narrow poly- and mono-dispersed anionic oligomers, and their uses, formulations and process |
10/26/1994 | EP0620828A1 Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof |
10/26/1994 | EP0620824A1 Peptides with tachykinin antagonist activity |
10/26/1994 | EP0620823A1 6,7$g(a)-DIFLUOROMETHYLENANDROSTA-1,4-DIEN-3-ONE DERIVATIVES AND PROCESS FOR THEIR PREPARATION |
10/26/1994 | EP0620821A1 Antiviral compositions and method for their use |
10/26/1994 | EP0620820A1 Novel substituted oxazinoisoquinoline derivatives, pharmaceutical compositions containing them and process for preparing same |
10/26/1994 | EP0620819A1 Antiparasitic agents |
10/26/1994 | EP0620818A1 ARYL KETONES AS TESTOSTERONE 5$g(a)-REDUCTASE INHIBITORS |
10/26/1994 | EP0620817A1 Piperazine derivatives as 5-ht receptors antagonists |
10/26/1994 | EP0620816A1 Novel thiosemicarbazonethiones |
10/26/1994 | EP0620815A1 Phenol derivatives as agonists of a cyclic amp dependent protein kinase |
10/26/1994 | EP0620814A1 Novel piprazine carboxamides |
10/26/1994 | EP0620813A1 Heterocyclic sulfonamide derivatives as antagonists of paf and angiotensin ii |
10/26/1994 | EP0620812A1 Quinolone derivatives |
10/26/1994 | EP0620811A1 Heterocycle-substituted benzylamine derivatives as antiretroviral compounds |
10/26/1994 | EP0620742A1 Inactivation of cytotoxic drugs |
10/26/1994 | EP0620741A1 Cytotoxic drug therapy |
10/26/1994 | EP0620738A1 Fibrinolysis and fibrinogenolysis treatment with plasmin |
10/26/1994 | EP0620736A1 A method for the treatment of tumours and sarcomas |
10/26/1994 | EP0620735A1 Use of ruthenium red for inhibiting immune response |
10/26/1994 | EP0620734A1 Therapeutic nucleosides |
10/26/1994 | EP0620733A1 Pharmaceutical compositions containing nifedipine and process for the preparation thereof |
10/26/1994 | EP0620732A1 Methods for using (2-imidazolin-2-ylamino) quinoxaline derivatives |
10/26/1994 | EP0527835B1 Dosage form to deliver an antiparkinson agent |
10/26/1994 | EP0486536B1 Antiviral compositions containing sulfoquinovosyl glycerol derivatives and analogs thereof |
10/26/1994 | EP0452390B1 Halo substituted aminotetralins |
10/26/1994 | EP0427747B1 Substituted phenylacetonitriles used to overcome resistance to drugs in anti-malarial therapy |
10/26/1994 | EP0192667B1 Device for initiating reperfusion treatment when heart attack symptoms are present |
10/26/1994 | CN1094057A Acetylglutaminylzinc and its preparation and usage |
10/26/1994 | CN1094056A N-oxycarbonyl substituted 5'-deoxy-5-fluorcytidines |
10/26/1994 | CN1094052A Heterocycle-containing carbonic acid derivatives |
10/26/1994 | CN1094051A Diaryl 5,6-fusedheterocyclic acids as leukotriene antagonists |
10/26/1994 | CN1094050A Novel heterocyclic compounds with antiasthmatic/anti-auergie, anti-inflammatory positive inotropic and blood pressure-reducing effect |
10/26/1994 | CN1094049A Use of imidazopyrazole derivatives as analgesics and anti-inflammatory agents |
10/26/1994 | CN1094048A Pyrazolopyrimidines |
10/26/1994 | CN1094047A 2-substituted methyl-2,3-dihydroimidazole |1,2-C¨ quinazoline-5-one )thione) and its preparation and usage |
10/26/1994 | CN1094046A Novel compounds |
10/26/1994 | CN1094045A Pyridopyrimidine derivatives, their production and use |
10/26/1994 | CN1094044A Imidazopyridines |
10/26/1994 | CN1094043A 喹唑啉衍生物 Quinazoline derivatives |
10/26/1994 | CN1094042A Improvements in or relating to benzothiophenes |
10/26/1994 | CN1094041A 6,7-modified paclitaxels |
10/26/1994 | CN1094038A Amino-substituted pyrazoles |
10/26/1994 | CN1094036A Novel asymmetrically substituted bisnaphthalimides |
10/26/1994 | CN1094035A Carboxylic acid derivatives, pharmaceutical compositions containing these compounds and processes for preparing them |
10/26/1994 | CN1094034A 25Carboxylic derivative of vitamin D series, middle products in production of same and pharmaceutical containing same and use of same in treatment |
10/26/1994 | CN1094031A Compounds |
10/26/1994 | CN1094030A Diaminobenzoic acid derivatives |
10/26/1994 | CN1094029A New acylamino acids |
10/26/1994 | CN1094028A Catechol diethers as selective PDE(IV) inhibitors |
10/26/1994 | CN1093905A Medicine-weisigaosi |
10/26/1994 | CN1093904A Compositions for the regulation of cytokine activity |
10/26/1994 | CN1093903A Enteroclysis medicine Liq.-Acidum pipemidicum syrup for curing diarrhea |
10/26/1994 | CN1093902A Solid reagent for penicillin skin test and its production method |
10/26/1994 | CN1093901A Stable pharmaceutical composition of fumagillol derivatives |
10/26/1994 | CN1093900A A medicine for curing dermatosis |
10/26/1994 | CN1093899A Ractopmine for pre-and peripubertal female bovidae |
10/26/1994 | CN1026324C 11beta-(4-isopropenylbenzene)-4,9-estrobiene, preparation of same and pharmaceutical containing same |
10/26/1994 | CN1026323C Novel sulfonylphenyl-beta-D-thioxylosides, their method of preparation and their use in therapeutics |
10/26/1994 | CN1026319C Pharmaceutical compositions |
10/25/1994 | US5359128 Malic acid derivatives and compositions for the treatment of psoriasis |
10/25/1994 | US5359124 Reacting benzylamine with cis-beta-phenylglycidic acid yields intermediate for anticarcinogenic taxol derivatives |
10/25/1994 | US5359120 Improvements relating to the production of prodrugs |
10/25/1994 | US5359098 Intermediates for making sigma binding site agents |
10/25/1994 | US5359096 Monocarboxylic derivatives of zaragozic acid |
10/25/1994 | US5359088 Enantiomerically pure aminopyrrolidine compounds |